ASTRAEA THERAPEUTICS, LLC
Biotech · Private
NOP receptor agonist small-molecule therapeutics for pain treatment
- Grants
- $2.2M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 5 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Development Of Novel Smoking Cessation Pharmacotherapies | $742,129 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Approach For Pain Treatment Without Opioid Liabilities | $760,015 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Development Of Novel Smoking Cessation Pharmacotherapies | $5,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Approach For Pain Treatment Without Opioid Liabilities | $736,013 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1155 | ENSIGN PHARMACEUTICAL, INC. | — | — |
| 1156 | ALLIANCE DISCOVERY, INC. | — | — |
| 1157 | PALENA THERAPEUTICS, INC. | — | — |
| 1158 | ASTRAEA THERAPEUTICS, LLC | — | — |
| 1159 | NEUTHERAPEUTICS, LLC | — | — |
| 1160 | IMAGO PHARMACEUTICALS, INC. | — | — |
| 1161 | Trove Labs Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Piperidinyl Nociceptin Receptor Compoundsapplication
- Piperidinyl Nociceptin Receptor Compoundsgranted
- Piperidinyl Nociceptin Receptor Compoundsgranted
- Piperdinyl Nociceptin Receptor Compoundsgranted
- Selective High Affinity Alpha3Beta4 Nicotinic Acetycholine Receptor Antagonistsapplication
- Piperdinyl Nociceptin Receptor Compoundsgranted
- Selective High Affinity ALFA3BETA4 Nicotinic Acetylcholine Receptor Antagonistsgranted
- Piperdinyl Nociceptin Receptor Compoundsapplication
- Nicotinic Acetylcholine Receptor Modulatorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.